BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406
22 results:

  • 1. Genetic Aspects of Conjunctival Melanoma: A Review.
    Chang E; Demirci H; Demirci FY
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
    Peretz Soroka H; Vora T; Noujaim J; Marcoux N; Cohen-Gogo S; Alcindor T; Holloway C; Rodrigues C; Karachiwala H; Alvi S; Lee U; Cheng S; Banerji S; Oberoi S; Feng X; Smrke A; Simmons C; Razak AA; Gupta AA
    Cancer Med; 2023 Sep; 12(18):18872-18881. PubMed ID: 37724607
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PBRM1 and bap1: novel genetic mutations in malignant transformation of craniopharyngioma-a case report.
    Tamura M; Yokogami K; Watanabe T; Kawano T; Muta J; Yamashita S; Oguri N; Sato Y; Takeshima H
    Brain Tumor Pathol; 2023 Jan; 40(1):40-44. PubMed ID: 36369599
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genome-wide aberrant methylation in primary metastatic UM and their matched metastases.
    Smit KN; Boers R; Vaarwater J; Boers J; Brands T; Mensink H; Verdijk RM; van IJcken WFJ; Gribnau J; de Klein A; Kilic E
    Sci Rep; 2022 Jan; 12(1):42. PubMed ID: 34997020
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Extrascleral extension of choroidal melanoma after iodine-125 brachytherapy treatment: a case series.
    Mustak H; Lo C; Cohen LM; Tran A; Almanzor R; McCannel TA; Goldberg RA; Rootman DB
    Eye (Lond); 2023 Feb; 37(2):249-255. PubMed ID: 34987200
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic Alterations in Melanocytoma Associated with Oculodermal Melanocytosis: Molecular Characteristics.
    Claxton MR; Dalvin LA; Guo R; Tooley AA
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):e77-e80. PubMed ID: 34919071
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
    Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic Profiling of Primary Orbital Melanoma: An Analysis of 6 Cases with Clinicopathologic Correlation.
    Mudhar HS; Doherty RE; Salvi SM; Currie ZI; Tan JH; Sisley K
    Ophthalmology; 2019 Jul; 126(7):1045-1052. PubMed ID: 30605742
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.
    Rose AM; Luo R; Radia UK; Kalirai H; Thornton S; Luthert PJ; Jayasena CN; Verity DH; Coupland SE; Rose GE
    BMC Cancer; 2018 Dec; 18(1):1262. PubMed ID: 30558566
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mutant ASXL1 cooperates with bap1 to promote myeloid leukaemogenesis.
    Asada S; Goyama S; Inoue D; Shikata S; Takeda R; Fukushima T; Yonezawa T; Fujino T; Hayashi Y; Kawabata KC; Fukuyama T; Tanaka Y; Yokoyama A; Yamazaki S; Kozuka-Hata H; Oyama M; Kojima S; Kawazu M; Mano H; Kitamura T
    Nat Commun; 2018 Jul; 9(1):2733. PubMed ID: 30013160
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.
    Hurtado AM; Luengo-Gil G; Chen-Liang TH; Amaral F; Batta K; Palomo L; Lumbreras E; Przychodzen B; Caparros E; Amigo ML; Dıez-Campelo M; Zamora L; Salido Fierrez EJ; Maciejewski JP; Ortuño FJ; Vicente V; Del Canizo M; Sole F; Ferrer-Marin F; Wiseman DH; Jerez A
    Br J Haematol; 2018 Aug; 182(3):373-383. PubMed ID: 29797327
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel
    Rodríguez-Moreno JF; Apellaniz-Ruiz M; Roldan-Romero JM; Durán I; Beltrán L; Montero-Conde C; Cascón A; Robledo M; García-Donas J; Rodríguez-Antona C
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1310-1315. PubMed ID: 29118224
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Bisphosphonates and other bone agents for breast cancer.
    O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Malignant Peripheral Nerve Sheath Tumor in a Patient With bap1 Tumor Predisposition Syndrome.
    Kaszuba MC; Pulido JS; Folpe AL; Pichurin PN; Goodenberger ML; Spinner RJ
    World Neurosurg; 2018 Jan; 109():362-364. PubMed ID: 29061454
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. BRCA1-Associated Protein-1 Suppresses Osteosarcoma Cell Proliferation and Migration Through Regulation PI3K/Akt Pathway.
    Gao S; Sun H; Cheng C; Wang G
    DNA Cell Biol; 2017 May; 36(5):386-393. PubMed ID: 28256910
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
    Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
    Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-bap1 complex.
    Balasubramani A; Larjo A; Bassein JA; Chang X; Hastie RB; Togher SM; Lähdesmäki H; Rao A
    Nat Commun; 2015 Jun; 6():7307. PubMed ID: 26095772
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
    Churi CR; Shroff R; Wang Y; Rashid A; Kang HC; Weatherly J; Zuo M; Zinner R; Hong D; Meric-Bernstam F; Janku F; Crane CH; Mishra L; Vauthey JN; Wolff RA; Mills G; Javle M
    PLoS One; 2014; 9(12):e115383. PubMed ID: 25536104
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Germline mutations in bap1 impair its function in DNA double-strand break repair.
    Ismail IH; Davidson R; Gagné JP; Xu ZZ; Poirier GG; Hendzel MJ
    Cancer Res; 2014 Aug; 74(16):4282-94. PubMed ID: 24894717
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.